IMPORTÂNCIA DA VIGILÂNCIA LABORATORIAL EM EMERGÊNCIAS DE SAÚDE PÚBLICA:

O EXEMPLO DO INSTITUTO ADOLFO LUTZ NO BRASIL

Autores

  • Amanda Izeli Portilho Instituto Adolfo Lutz/ Universidade de São Paulo
  • Gabriela Trzewikoswki de Lima Instituto Adolfo Lutz/Universidade de São Paulo
  • Elizabeth De Gaspari Instituto Adolfo Lutz/Universidade de São Paulo

Palavras-chave:

Public-health surveillance, Laboratory surveillance, Infectious diseases

Resumo

A saúde pública é uma questão importante. Tratando-se do controle das doenças infecciosas, a vigilância laboratorial permite identificar e monitorar patógenos, aprofundando a compreensão de sua biologia e epidemiologia, que variam ao longo do tempo. Esses pontos são exemplificados pelos serviços do Instituto Adolfo Lutz no Brasil, os quais começaram à época do entendimento sobre os microrganismos e se estenderam até hoje, durante a era da vigilância genômica de novas variantes de SARS-CoV-2. As atividades deste instituto de pesquisa colaboraram com o controle de diversas doenças, exemplificado nesta revisão pela Doença Meningocócica, endêmica, bem como para responder às epidemias de Influenza H1N1 em 2009 e à atual COVID-19. As atividades laboratoriais ajudam a entender a dinâmica das doenças infecciosas, permitindo seu controle e alcance de melhor qualidade de vida para a população, que são objetivos da saúde pública.

Palavras-chave: Vigilância em saúde pública, Vigilância laboratorial, Doenças infecciosas.

Biografia do Autor

Amanda Izeli Portilho, Instituto Adolfo Lutz/ Universidade de São Paulo

Amanda Izeli Portilho is a Master student at the Post-graduate Program Interunits in Biotechnology, of University of São Paulo, developing her project at  the Immunology Center of Adolfo Lutz Institute, both located in São Paulo, SP, Brazil. Received her Bachelor Degree in Biomedicine (2017) from Centro Universitário Central Paulista (São Carlos, São Paulo, SP). She is a Specialist in Laboratory Surveillance in Public Health (2019) for the São Paulo State Health Secretary Program at Adolfo Lutz Institute. She has experience in Immunology and Molecular Biology for public health diseases. Currently studies mucosal immunization strategy against Neisseria meningitidis at Elizabeth De Gaspari’s Lab.

Gabriela Trzewikoswki de Lima, Instituto Adolfo Lutz/Universidade de São Paulo

Gabriela Trzewikoswki de Lima is Bachelor in Pharmacy, from Cruzeiro do Sul University (2015). She concluded the Immunology and Molecular Biology Applied for Diseases of Public Health's Interest Program of the São Paulo State Health Secretary at Adolfo Lutz Institute (2018). She has a Master degree in Sciences from the Post-graduate Program Interunits in Biotechnology, of the University of São Paulo (2020). She has expertise in immunology, vaccinology and molecular biology.

Elizabeth De Gaspari, Instituto Adolfo Lutz/Universidade de São Paulo

Elizabeth De Gaspari is a Researcher Scientist at Immunology Center of Adolfo Lutz Institute, and Professor at the Post-graduate Program Interunits in Biotechnology, of University of São Paulo, both located in São Paulo, SP, Brazil. She is a bachelor in Biomedicine (1978) from Santo Amaro University. Has a Master Degree (1983) in Microbiology and Immunology, from the Federal University of São Paulo (São Paulo, SP). Obtained her Ph.D degree (1990) in Immunology, from the University of São Paulo (São Paulo, SP). Was a Post-doc fellow (1992) in the Walter Reed Army Institute of Research (Washington, DC, USA). Collaborated with different institutions abroad. She has experience in Immunology, with emphasis on the topics: neonatal immunology, maternal-fetal interaction, mucosal immunology, adjuvants and monoclonal antibodies. Her studies had focused on Neisseria meningitidis, but currently, she is also studying immune response and vaccine platforms for SARS-CoV-2.

Referências

ABEBE, Endeshaw Chekol, et al. The newly emerged COVID-19 disease: A systemic review. Virology Journal, v. 17, n. 1, p. 96, 2020.

ADIL, Tanveer, et al. SARS-CoV-2 and the pandemic of COVID-19. Postgraduate Medical Journal, v. 97, n. 1144, p. 110-116, 2020.

ALFARAJ, Sarah H., et al. Clinical predictors of mortality of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection: A cohort study. Travel Medicine and Infectious Diseases, v. 29, p. 48–50, 2019.

BARRETO, Mauricio L., et al. Successes and failures in the control of infectious diseases in Brazil: Social and environmental context, policies, interventions, and research needs. The Lancet. v. 377, n. 9780, p.1877–89, 2011.

BENCHIMOL, Jaime Larry. A instituição da microbiologia e a história da saúde pública no Brasil. Ciência e Saúde Coletiva, v. 5, n. 2, p. 265–92, 2000.

BENCHIMOL, Jaime Larry. Adolpho Lutz: a biographical sketch. História, Ciência e Saúde-Manguinhos, v. 10, n. 1, p. 13–83, 2003.

BORROW, Ray, et al. Effectiveness of meningococcal serogroup C vaccine programmes. Vaccine, v. 31, n. 41, p. 4477–86, 2013.

BROWER, Jennifer L. The Threat and Response to Infectious Diseases (Revised). Microbial Ecology, v. 76, n. 1, p. 19–36, 2018.

CAMARGO, Erney Plessmann; SANT’ANNA, Oswaldo Augusto. Institutos de pesquisa em saúde. Ciência e Saúde Coletiva, v. 9, n. 2, p. 295–302, 2004.

CARMO, Eduardo Hage; PENNA, Gerson; de OLIVEIRA, Wanderson Kleber. Emergências de saúde pública: Conceito, caracterização, preparação e resposta. Estudos Avançados, v. 22, n. 64, p. 19–32, 2008.

CHIEFFI, Pedro Paulo; WALDMAN, Eliseu Alves. Instituto Adolfo Lutz 1940-1984, desafios de um laboratório de saúde pública. Revista do Instituto Adolfo Lutz, v. 46, n. 1/2, p. 19–25, 1986.

CUNNINGHAM, Andrew A; DASZAK, Peter; WOOD, James LN. One health, emerging infectious diseases and wildlife: Two decades of progress? Philosophical Transactions of the Royal Society of London, Series B - Biological Sciences, v.372, n. 1725, p. 20160167, 2017.

DOHERTY, Jo Anne. Establishing priorities for national communicable disease surveillance. The Canadian Journal of Infectious Diseases, v. 11, n. 1, p. 21–4, 2000.

ERWIN, Paul Campbell; BROWNSON, Ross C. Macro Trends and the Future of Public Health Practice. Annual Review of Public Health, v. 38, p. 393–412, 2017.

FINKELMAN, Jacobo (org). Caminhos da Saúde Pública no Brasil. 1 ed. Rio de Janeiro: Editora Fiocruz; 2002. 328 p. Disponível em: https://www.paho.org/bra/dmdocuments/caminhos%20da%20saude%20publica%20no%20brasil.pdf. Acesso em 11 de junho de 2021.

FRED, João, et al. Vigilância da influenza A (H1N1), novo subtipo viral, no Estado de São Paulo, 2009. Bepa - Boletim Epidemiológico Paulista, v. 6, n. 65, p. 4–15, 2009.

FUKASAWA, Lucila Okuyama, et al. Implantação e otimização da PCR em tempo real para o diagnóstico da influenza A (H1N1) pandêmica no Instituto Adolfo Lutz e perspectivas para 2010. Revista do Instituto Adolfo Lutz, v. 69, n. 1, p. 131–5, 2010.

GAMBLIN, Steven J; SKEHEL, John J. Influenza hemagglutinin and neuraminidase membrane glycoproteins. Journal of Biological Chemistry, v. 285, n. 37, p. 28403–28409, 2010.

GARDY, Jennifer L; LOMAN, Nicholas J. Towards a genomics-informed, real-time, global pathogen surveillance system. Nature Reviews Genetics, v. 19, n. 1, p. 9–20, 2018.

GOVERNO DO ESTADO DE SÃO PAULO. Adolfo Lutz completa 70 anos de combate a epidemias. 2010. Disponível em: https://www.saopaulo.sp.gov.br/ultimas-noticias/adolfo-lutz-completa-70-anos-de-combate-a-epidemias/#:~:text=O%20Instituto%20Adolfo%20Lutz%2C%20%C3%B3rg%C3%A3o,28%2C%2070%20anos%20de%20atividades. Acesso em 11 de junho de 2021.

GRAY, John A Muir. Evidence-based public health-what level of competence is required? Journal of Public Health Medicine, v. 19, n. 1, p. 65–68, 1997.

GROSECLOSE, Samuel L; BUCKERIDGE, David L. Public Health Surveillance Systems: Recent Advances in Their Use and Evaluation. Annual Review of Public Health, v. 38, p. 57–79, 2017.

HEYMANN, David L; RODIER, Guénaël R. Globalization and Health: The Need for Global Surveillance. Emerging Infectious Diseases, v. 4, n. 3, p. 362–5, 1998.

INSTITUTO ADOLFO LUTZ. A atuação do Instituto Adolfo Lutz no enfrentamento à pandemia da Covid-19. 2020. Disponível em: https://docs.bvsalud.org/biblioref/2020/04/1095266/atuacao_ial_covid-19_abr2020.pdf. Acesso em 11 de junho de 2021.

INSTITUTO ADOLFO LUTZ. SARS-COV-2 Monitoramento. Rev Inst Adolfo Lutz. 2021;1–21. Disponível em: http://www.ial.sp.gov.br/resources/insituto-adolfo-lutz/publicacoes/report-epigenomica_05jiun/report_epigenomica_drs_05jun.pdf. Acesso em 11 de junho de 2021.

JAYATILLEKE, Nishamali; MACKIE, Anne. Reflection as part of continuous professional development for public health professionals: A literature review. Journal of Public Health (United Kingdom), v. 35, n. 2, p. 308–312, 2013.

de JESUS, Jaqueline Goes, et al. Importation and early local transmission of COVID-19 in Brazil, 2020. Revista do Instituto de Medicina Tropical de São Paulo, v. 62, p. 1–5, 2020.

KLEPAC, Petra, et al. Six challenges in the eradication of infectious diseases. Epidemics, v. 10, p. 97–101, 2015.

KRAMMER, Florian. SARS-CoV-2 vaccines in development. Nature, v. 586, n. 7830, p. 516–27, 2020.

LAGUARDIA, José, et al. Sistema de Informação de Agravos de Notificação (Sinan): desafios no desenvolvimento de um sistema de informação em saúde. Epidemiologia e Serviços de Saúde, v. 13, n. 3, p. 135–46, 2004.

LIU, Yen-Chin; KUO, Rei-Lin; SHIH, Shin-Ru. COVID-19: The first documented coronavirus pandemic in history. Biomedical Journal, v. 43, n. 4, p. 328–333, 2020.

McFEE, R B. SARS2 HUMAN CORONAVIRUS (COVID-19, SARS-CoV-2). Disease-a-Month, v. 66, n. 9, p. 101063, 2020.

MINISTÉRIO DA SAÚDE DO BRASIL. Guia para a Rede Laboratorial de Vigilância de Influenza no Brasil. 2016. Disponível em: https://bvsms.saude.gov.br/bvs/publicacoes/guia_laboratorial_influenza_vigilancia_influenza_brasil.pdf. Acesso em 11 de junho de 2021.

MINISTÉRIO DA SAÚDE DO BRASIL. Informe Técnico: Orientações técnico-operacionais para a Vacinação dos Adolescentes com a Vacina Meningocócica ACWY (conjugada). 2020a. Disponível em: http://vigilancia.saude.mg.gov.br/index.php/download/informe-tecnico-orientacoes-tecnico-operacionais-para-a-vacinacao-dos-adolescentes-com-a-vacina-meningococica-acwy-conjugada/?wpdmdl=7604. Acesso em 11 de junho de 2021.

MINISTÉRIO DA SAÚDE DO BRASIL. Coronavírus Brasil. 2020b. Disponível em: https://covid.saude.gov.br/. Acesso em 30 de agosto de 2021.

MISHRA, Sanjay Kumer; TRIPATHI, Timir. One year update on the COVID-19 pandemic: Where are we now? Acta Tropica, v. 214, p. 105778, 2021.

MORAES, José Cassio; BARATA, Rita Barradas. A doença meningocócica em São Paulo, Brasil, no século XX: características epidemiológicas. Caderno de Saúde Pública, v. 21, n. 5, p.1458–1471, 2005.

MORAES, José Cassio, et al. Prevalence, risk factors and molecular characteristics of meningococcal carriage among brazilian adolescents. Pediatric Infectious Disease Journal, v. 34, n. 11, p. 1197–202, 2015.

MORENS, David M; FOLKERS, Gregory K, FAUCI, Anthony S. Erratum: The challenge of emerging and re-emerging infectious diseases. Nature, v. 463, n. 7277, p. 122, 2010.

NII-TREBI, Nicholas Israel. Emerging and Neglected Infectious Diseases: Insights, Advances, and Challenges. BioMed Research International, v. 2017, p. 5245021, 2017.

OLSHAN, Andrew F, et al. Epidemiology: Back to the Future. American Journal of Epidemiology, v. 188, n. 5, p. 814–817, 2019.

OLWENYI, Omalla A, et al. Immuno-epidemiology and pathophysiology of coronavirus disease 2019 (COVID-19). Journal of Molecular Medicine (Berl), v. 98, n. 10, p. 1369-1383, 2020.

PAIM, Jairnilson, et al. The Brazilian health system: History, advances, and challenges. The Lancet, v. 377, n. 9779, p. 1778–1797, 2011.

PETERSEN, Eskild, et al. Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics. Lancet Infectious Diseases, v. 20, n. 9, p. E238-E244, 2020.

PORTILHO, Amanda Izeli; TRZEWIKOSWKI DE LIMA, Gabriela; DE GASPARI, Elizabeth. Neisseria meningitidis: analysis of pili and LPS in emerging Brazilian strains. Therapeutic Advances in Vaccines and Immunotherapy, v. 8, p. 251513552091919, 2020.

RILEY, Lee W; BLANTON, Ronald E. Advances in Molecular Epidemiology of Infectious Diseases: Definitions, Approaches, and Scope of the Field. Microbiology Spectrum, v. 6, n. 6, p. 1–12, 2018.

ROZENFELD, Suely. Fundamentos de Vigilância Sanitária. 1 ed. Rio de Janeiro: Editora Fiocruz; 2000. 304 p. Disponível em: https://static.scielo.org/scielobooks/d63fk/pdf/rozenfeld-9788575413258.pdf. Acesso em 11 de junho de 2021.

SACCHI, Claudio Tavares, et al. Ongoing group B Neisseria meningitidis epidemic in Sao Paulo, Brazil, due to increased prevalence of a single clone of the ET-5 complex. Journal of Clinical Microbiology, v. 30, n. 7, p. 1734–1738, 1992.

SÁFADI, Marco Aurelio Palazzi; BEREZIN, Eitan Naaman; OSELKA, Gabriel Wolf. Análise crítica das recomendações do uso das vacinas meningocócicas conjugadas. Jornal de Pediatria (Rio de Janeiro), v. 88, n. 3, p. 195–202, 2012.

SANTOS-NETO, José Francisco, et al. Carriage prevalence of Neisseria meningitidis in the Americas in the 21st century: a systematic review. Brazilian Journal of Infectious Diseases, v. 23, n. 4, p. 254–267, 2019.

SECRETARIA DO ESTADO DA SAÚDE (São Paulo) - Instituto Adolfo Lutz. Informação da vigilância das pneumonias e meningites bacterianas: Sireva II. Coord Control Doenças. 2016. Disponível em: https://www.saude.pr.gov.br/sites/default/arquivos_restritos/files/documento/2020-04/sireva_2017_2.pdf. Acesso em 11 de junho de 2021.

SECRETARIA DE VIGILÂNCIA EM SAÚDE. Informe técnico de Influenza. 2012. Disponível em: https://bvsms.saude.gov.br/bvs/publicacoes/guia_laboratorial_influenza_vigilancia_influenza_brasil.pdf. Acesso em 11 de junho de 2021.

SHEARS, Paul. Communicable disease surveillance with limited resources: The scope to link human and veterinary programmes. Acta Tropica, v. 76, n. 1, p. 3–7, 2000.

SIERRA-GONZÁLEZ, Gustavo. Cuban meningococcal vaccine VA-MENGOC-BC®: 30 years of use and future potential. Vaccimonitor, v. 29, n. 1, p. 31–43, 2020.

da SILVA, Luiz Jacintho. Public health challenges and emerging diseases: the case of São Paulo. Cadernos de Saúde Pública, v. 17, p. 141–146, 2001.

THIÉBAUT, Rodolphe, THIESSARD, Frantz. Public Health and Epidemiology Informatics. Yearbook of Medical Informatics, v. 26, n. 1, p. 248–51, 2017.

WANG, Jieliang, et al. The COVID-19 Vaccine Race: Challenges and Opportunities in Vaccine Formulation. AAPS PharmSciTech, v. 21, n. 6, p. 225, 2020.

WEIDLICH, Luciana, et al. High prevalence of Neisseria meningitidis hypervirulent lineages and emergence of W135:P1.5,2:ST-11 clone in Southern Brazil. Journal of Infection, v. 57, n. 4, p. 324–331, 2008.

WHO. An integrated approach to communicable disease surveillance. Weekly Epidemiological Record, v. 1, n. 75, p. 1–8, 2000a.

WHO. WHO report on global surveillance of epidemic-prone infectious diseases. 2000b. Disponível em: https://www.who.int/csr/resources/publications/surveillance/WHO_Report_Infectious_Diseases.pdf?ua=1. Acesso em 11 de junho de 2021.

WHO. Protocol for the assessment of national communicable disease surveillance and response systems. Guidelines for assessment teams. 2001. Disponível em: https://www.who.int/csr/resources/publications/surveillance/whocdscsrisr20012.pdf?ua=1. Acesso em 11 de junho de 2021.

WHO. Consensus document on the epidemiology of severe acute respiratory syndrome (SARS). 2003. Disponível em: https://apps.who.int/iris/bitstream/handle/10665/70863/WHO_CDS_CSR_GAR_2003.11_eng.pdf?sequence=1&isAllowed=y. Acesso em 11 de junho de 2021.

WHO. Communicable disease surveillance and response systems. A guide to Planning. World Health. 2006. Disponível em: https://www.who.int/csr/resources/publications/surveillance/WHO_CDS_EPR_LYO_2006_2.pdf. Acesso em 11 de junho de 2021.

WHO. WHO Collaborating Centre for Reference and Research on Influenza. WHO Global Influenza Surveillance Network (GISN) Surveillance and Vaccine Development. Meeting Report 2010. Disponível em: http://www.influenzacentre.org/centre_GISN.htm. Acesso em 11 de junho de 2021.

WHO. WHO/Europe | Coronavirus disease (COVID-19) outbreak - About the virus. 2020a. Disponível em: https://www.euro.who.int/en/health-topics/health-emergencies/coronavirus-covid-19/novel-coronavirus-2019-ncov. Acesso em 11 de junho de 2021.

WHO. WHO Director-General’s statement on IHR Emergency Committee on Novel Coronavirus (2019-nCoV). 2020b. Disponpivel em: https://www.who.int/director-general/speeches/detail/who-director-general-s-statement-on-ihr-emergency-committee-on-novel-coronavirus. Acesso em 11 de junho de 2021.

WHO. WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020. 2020c. Disponível em: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020. Acesso em 11 de junho de 2021.

WHO. WHO Coronavirus Disease (COVID-19) Dashboard. 2020d. Disponível em: https://covid19.who.int/. Acesso em 11 de junho de 2021.

WINSLOW, Charles-Edward Amory. The untilled fields of public health. Science, v. 51, p. 23-33, 1920.

WU, Zunyou, McGOOGAN, Jennifer M. Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases from the Chinese Center for Disease Control and Prevention. JAMA, v. 323, n. 13, p. 1239–1242, 2020.

Downloads

Publicado

2021-12-21

Como Citar

Izeli Portilho, A., Trzewikoswki de Lima, G., & De Gaspari, E. (2021). IMPORTÂNCIA DA VIGILÂNCIA LABORATORIAL EM EMERGÊNCIAS DE SAÚDE PÚBLICA: : O EXEMPLO DO INSTITUTO ADOLFO LUTZ NO BRASIL. Revista Brasileira De Biomedicina, 1(1). Recuperado de https://revistadabiomedicina.com.br/index.php/12222/article/view/53

Edição

v. 1 n. 1 (2021): Revista Brasileira de Biomedicina- RBB.

Seção

Artigos

Licença

Copyright (c) 2021 Revista Brasileira de Biomedicina -RBB

Creative Commons License

Este trabalho está licenciado sob uma licença Creative Commons Attribution-NonCommercial 4.0 International License.